Intraoperative electrochemotherapy of colorectal liver metastases

Journal of Surgical Oncology

Volumn 110, Issue 3, 2014, Pages 320-327

  Edhemovic, Ibrahim ^a   Brecelj, Erik ^a   Gasljevic, Gorana ^a   Marolt Music, Maja ^a   Gorjup, Vojka ^b   Mali, Barbara ^c   Jarm, Tomaz ^c   Kos, Bor ^c   Pavliha, Denis ^c   Grcar Kuzmanov, Biljana ^a   Cemazar, Maja ^a   Snoj, Marko ^a   Miklavcic, Damijan ^c   Gadzijev, Eldar M ^a   Sersa, Gregor ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

ablation; bleomycin; electroporation; liver neoplasms; safety; treatment effectiveness

Indexed keywords

BLEOMYCIN;

ADULT; AGED; ARTICLE; CANCER TISSUE; CHEMOSURGERY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COLORECTAL LIVER METASTASIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCHEMOTHERAPY; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; NEEDLE ELECTRODE; PATIENT SAFETY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE GENERATOR; REOPERATION; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE;

ABLATION; BLEOMYCIN; ELECTROPORATION; LIVER NEOPLASMS; SAFETY; TREATMENT EFFECTIVENESS;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; COLORECTAL NEOPLASMS; ELECTROCARDIOGRAPHY; ELECTROCHEMOTHERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; INTRAOPERATIVE CARE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NECROSIS; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 84905402487     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23625     Document Type: Article

References (49)

1. Alberts SR:, Update on the optimal management of patients with colorectal liver metastases. Crit Rev Oncol Hematol 2012; 84: 59-70.
2. Wong SL, Mangu PB, Choti MA, et al.: American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010; 28: 493-508.
3. Maor E, Ivorra A, Leor J, et al.: The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 2007; 6: 307-312.
4. Cheung W, Kavnoudias H, Roberts S, et al.: Irreversible electroporation for unresectable hepatocellular carcinoma: Initial experience and review of safety and outcomes. Technol Cancer Res Treat 2013; 12: 233-241.
5. Orlowski S, Belehradek J Jr, Paoletti C, et al.: Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988; 37: 4727-4733.
6. Sersa G, Cemazar M, Miklavcic D:, Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 1995; 55: 3450-3455.
7. Marty M, Sersa G, Garbay JR, et al.: Electrochemotherapy-An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4: 3-13.
8. Mir LM, Gehl J, Sersa G, et al.: Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator™ by means of invasive or non-invasive electrodes. Eur J Cancer Suppl 2006; 4: 14-25.
9. Eggermont AM:, Treatment of melanoma in-transit metastases confined to the limb. Cancer Surv 1996; 26: 335-349.
10. Jaroszeski MJ, Dang V, Pottinger C, et al.: Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs 2000; 11: 201-208.
11. Todorovic V, Sersa G, Flisar K, et al.: Enhanced cytotoxicity of bleomycin and cisplatin after electroporation in murine colorectal carcinoma cells. Radiol Oncol 2009; 43: 264-273.
12. Matthiessen LW, Chalmers RL, Sainsbury DCG, et al.: Management of cutaneous metastases using electrochemotherapy. Acta Oncol 2011; 50: 621-629.
13. Matthiessen LW, Johannesen HH, Hendel HW, et al.: Electrochemotherapy for large cutaneous recurrence of breast cancer: A phase II clinical trial. Acta Oncol 2012; 51: 713-721.
14. Campana LG, Valpione S, Mocellin S, et al.: Electrochemotherapy for disseminated superficial metastases from malignant melanoma. Br J Surg 2012; 99: 821-830.
15. Campana LG, Valpione S, Falci C, et al.: The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: A phase-II study. Breast Cancer Res Treat 2012; 134: 1169-1178.
16. Sersa G, Cufer T, Paulin SM, et al.: Electrochemotherapy of chest wall breast cancer recurrence. Cancer Treat Rev 2012; 38: 379-386.
17. Latini A, Bonadies A, Trento E, et al.: Effective treatment of Kaposi's sarcoma by electrochemotherapy and intravenous bleomycin administration. Dermatol Ther 2012; 25: 214-218.
18. Gargiulo M, Papa A, Capasso P, et al.: Electrochemotherapy for non-melanoma head and neck cancers: Clinical outcomes in 25 patients. Ann Surg 2012; 255: 1158-1164.
19. Curatolo P, Quaglino P, Marenco F, et al.: Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: A two-center prospective phase II trial. Ann Surg Oncol 2012; 19: 192-198.
20. Testori A, Faries MB, Thompson JF, et al.: Local and intralesional therapy of in-transit melanoma metastases. J Surg Oncol 2011; 104: 391-396.
21. Mali B, Miklavcic D, Campana LG, et al.: Tumor size and effectiveness of electrochemotherapy. Radiol Oncol 2013; 47: 32-41.
22. Miklavcic D, Sersa G, Brecelj E, et al.: Electrochemotherapy: Technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput 2012; 50: 1213-1225.
23. Jahangeer S, Forde P, Soden D, et al.: Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours. Cancer Treat Rev 2013; 39: 862-871.
24. Edhemovic I, Gadzijev EM, Brecelj E, et al.: Electrochemotherapy: A new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat 2011; 10: 475-485.
25. Miklavcic D, Snoj M, Zupanic A, et al.: Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy. Biomed Eng OnLine 2010; 9: 10.
26. Pavliha D, Kos B, Zupanic A, et al.: Patient-specific treatment planning of electrochemotherapy: Procedure design and possible pitfalls. Bioelectrochemistry 2012; 87: 265-273.
27. Zupanic A, Kos B, Miklavcic D:, Treatment planning of electroporation-based medical interventions: Electrochemotherapy, gene electrotransfer and irreversible electroporation. Phys Med Biol 2012; 57: 5425-5440.
28. Reilly JP, editor: Applied bioelectricity: From electrical stimulations to electropathology. New York: Springer; 1998.
29. Mali B, Jarm T, Corovic S, et al.: The effect of electroporation pulses on functioning of the heart. Med Biol Eng Comput 2008; 46: 745-757.
30. Ball C, Thomson KR, Kavnoudias H:, Irreversible electroporation: A new challenge in 'out of operating theater' anesthesia. Anesth Analg 2010; 110: 1305-1309.
31. Deodhar A, Dickfeld T, Single GW, et al.: Irreversible electroporation near the heart: Ventricular arrhythmias can be prevented with ECG synchronization. Am J Roentgenol 2011; 196: W330-W335.
32. Ribero D, Wang H, Donadon M, et al.: Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 2007; 110: 2761-2767.
33. Chang HHL, Leeper WR, Chan G, et al.: Infarct-like necrosis: A distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy. Am J Surg Pathol 2012; 36: 570-576.
34. Lencioni R, Llovet JM:, Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30: 52-60.
35. Park M, Rhim H, Kim Y, et al.: Spectrum of CT findings after radiofrequency ablation of hepatic tumors. Radiographics 2008; 28: 379-390.
36. Mali B, Jarm T, Snoj M, et al.: Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis. EJSO 2013; 39: 4-16.
37. Soden DM, Larkin JO, Collins CG, et al.: Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours. Cancer Lett 2006; 232: 300-310.
38. Linnert M, Iversen HK, Gehl J:, Multiple brain metastases-Current management and perspectives for treatment with electrochemotherapy. Radiol Oncol 2012; 46: 271-278.
39. Crocetti L, Lencioni R, Debeni S, et al.: Targeting liver lesions for radiofrequency ablation: An experimental feasibility study using a CT-US fusion imaging system. Invest Radiol 2008; 43: 33-39.
40. Testori A, Tosti G, Martinoli C, et al.: Electrochemotherapy for cutaneous and subcutaneous tumor lesions: A novel therapeutic approach. Dermatol Ther 2010; 23: 651-661.
41. Thomson K:, Human experience with irreversible electroporation. In:, Rubinsky B, editor. Irreversible electroporation. Berlin Heidelberg: Springer-Verlag; 2010. pp. 249-254.
42. Pech M, Janitzky A, Wendler JJ, et al.: Irreversible electroporation of renal cell carcinoma: A first-in-man phase I clinical study. Cardiovasc Intervent Radiol 2011; 34: 132-138.
43. Bagla S, Papadouris D:, Percutaneous irreversible electroporation of surgically unresectable pancreatic cancer: A case report. J Vasc Interv Radiol 2012; 23: 142-145.
44. Sersa G, Jarm T, Kotnik T, et al.: Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 2008; 98: 388-398.
45. Jarm T, Cemazar M, Miklavcic D, et al.: Antivascular effects of electrochemotherapy: Implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 2010; 10: 729-746.
46. Neal RE II, Rossmeisl JH Jr, Garcia PA, et al.: Successful treatment of a large soft tissue sarcoma with irreversible electroporation. J Clin Oncol 2011; 29: e372-e377.
47. Charpentier KP:, Irreversible electroporation for the ablation of liver tumors: Are we there yet ? Arch Surg 2012; 147: 1053-1061.
48. Czymek R, Nassrallah J, Gebhard M, et al.: Intrahepatic radiofrequency ablation versus electrochemical treatment in vivo. Surg Oncol 2012; 21: 79-86.
49. Neal RE II, Kavnoudias H, Cheung W, et al.: Hepatic epithelioid hemangioendothelioma treated with irreversible electroporation and antibiotics. J Clin Oncol 2013; 31: e422-e426.